Navigation Links
Mirixa's Healthcare Success in Software-as-a-Service and IT/Business Integration Recognized in Gartner Publication
Date:3/20/2008

RESTON, Va., March 20 /PRNewswire/ -- Mirixa Corporation announced today that its strategic use of Information Technology was recently highlighted by Gartner's EXP CIO Signature, a high-level industry publication targeted exclusively to CIO of major corporations.

The October 2007 issue of Gartner EXP CIO Signature, "Getting the Right IT: Using Business Models," written by Richard Hunter, described how CEOs can ensure they are getting the right IT for their companies and examined working business models to give industry leaders new insights. Mirixa was featured along with other industry leaders including Weyerhaeuser, Siemens AG, and ABB.

"The perennial challenge for any CIO is how to align IT with the business," said Carberry. "What Mirixa has been able to do is develop a user-friendly IT platform to reach a critical sector of the healthcare industry -- pharmacists -- and provide them with services that generate a new revenue stream and work toward improving patient health, thereby enabling the business model for our company."

Mirixa operates by providing technology and supportive services to pharmacies, pharmacists and their patients through its Software-As-A-Service (SaaS) web-based solution, MirixaPro(SM). Mirixa's innovative clinical solutions suite enables pharmacists to easily deliver patient care services in conjunction with healthcare providers to achieve improved patient outcomes, lower operating costs, and to produce patient care revenues in addition to pharmacies' traditional dispensing and merchandising business.

"Everything we do is enabled by our IT platform," said Carberry. "We may be new to the industry, but this platform has successfully scaled with our business and produced positive impact on the ability of pharmacists to deliver clinical patient care services that improve safety, quality of care, and ultimately control healthcare costs."

About Mirixa

Mirixa Corporation is a leader in targeted patien
'/>"/>

SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. eMPR Digital Drug Reference Reaches 50,000 Downloads and the Publisher Launches a Raffle for Healthcare Providers
2. Aflac Reaches $40 Million Milestone in Donations to the Aflac Cancer Center and Blood Disorders Service of Childrens Healthcare of Atlanta
3. Flagship Global Health and China HealthCare Holdings Form Strategic Alliance
4. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
5. On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group
6. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
7. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
8. Cardinal Health, GE Healthcare Broaden Relationship to Offer Greater Access to Myoview(TM) Imaging Agent
9. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
10. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
11. Unions Successful in Targeting Healthcare Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... The Restore My Blood Sugar review recently published ... levels can now find an amazingly successful method of reducing ... created by D. Chao and Andrew Forester who claim that ... it comes to normalizing blood sugar levels. Chao actually is ... to the cure of diabetes that all patients should find ...
(Date:7/30/2014)... July 30, 2014 New changes are in ... plans to move to a new facility. The official date ... will be moving soon. , MedX Pharmacy will be moving ... Pearland, TX 77581. This is the old Wells Fargo building. ... and will include a drive thru for convenient drop-off and ...
(Date:7/30/2014)... Conducting Advanced Root Cause Analysis ... and Innovative Techniques to Improve the Quality of ... Sept. 17-18, 2014 – Raleigh, NC, http://www.fdanews.com/CAPAWorkshopRaleigh ... for 483 observations since 1997. , The FDA's ... CAPA program has never been more important. , ...
(Date:7/30/2014)... drug to treat malaria, is now widespread throughout ... ( P. falciparum ) parasites that cause the ... mutation in the parasites. However, a six-day course ... three-day coursehas proved highly effective in treating drug-resistant ... the New England Journal of Medicine . ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- It can happen in ... television, dresser or computer monitor and gets critically injured when ... a young child should look around their homes and imagine ... child. Imagining it is better than it becoming a reality," ... Physicians, said in a college news release. Between 2009 ...
Breaking Medicine News(10 mins):Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:MedX Pharmacy Relocates to New Facility 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 4Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Tip-Over Furniture Can Kill Kids 2
... WASHINGTON and DUBLIN , March ... Ireland -based, physician-led global certification company, today announced that ... Mark on its new LuV300 vacuum with Kompressor® technology. ... range of products from worldwide manufacturers to determine their ...
... ... , ... ... On Thursday, March 18 , lawyers from the U.S. Department of Justice will appear in Federal District ...
... Care to Pay for It Makes Little Sense , ... ... PRINCETON, N.J. , March 16 Statement ... , , ...
... and suffering caused by antibiotic-resistant bacterial infections continue to rise ... (IDSA) is urging a global commitment to develop 10 new ... to address this public health crisis and safeguard patients, health. ... a statementpublished in the April 15 issue of Clinical ...
... has long been identified as a risk factor for cardiovascular ... researchers at the University of Rochester Medical Center found that ... risk of dying suddenly from cardiac causes. Scientists found ... underweight patients had a 76 percent increase in risk ...
... ... a new laundry detergent for U.S. consumers concerned about their budget as well as ... contains 10 ounces of macro-molecule laundry detergent which cleans for up to 12 months ... over 200 washes. , ...
Cached Medicine News:Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 2Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 3Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 4Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 5Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 2Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 3Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 4Health News:NJHA: Charity Care Must Be a Priority as Uninsured Burden Grows 2Health News:ID physicians call for 10 new antibiotics by 2020 2Health News:As girth grows, risk of sudden cardiac death shrinks 2Health News:As girth grows, risk of sudden cardiac death shrinks 3Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 2Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 3
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
Breaking Medicine Technology:InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and ... Sachs Global Healthcare Conference on Tuesday, June 15 , at ... Los Angeles .  The presentation will be webcast on the following ... , ...
... Epocal, Inc., a leading edge provider of point ... Food and Drug Administration (FDA) clearance to market its new ... from the epoc System are used to evaluate acid-base status ... acidity of the blood).  The addition of lactate to the ...
Cached Medicine Technology:Epocal Announces FDA Clearance of Lactate Test 2
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
... benchtop fume hood ventilates and ... indoor release of exhaust. Bonded ... contaminants. Configurations are available with ... include final HEPA filter, work ...
... proof polypropylene exhaust hoods are designed to ... and draw a stream of air across ... the operator. Other sizes and types of ... double-slot are available on special order in ...
... Benchtop Fume Hood is an economical unit ... which a number of fume hoods are ... colleges and universities. Features include a one-piece ... rounded inside corners for easy cleaning. A ...
Medicine Products: